Graft Dysfunction
📧 Sign up to get email alerts when something new happens for Graft Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction [Phase 2]
A Phase 2 clinical trial is assessing the safety and efficacy of an immune-inhibition strategy to prevent primary graft dysfunction in lung …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction [NA]
A University Health Network study is evaluating enhanced preservation therapy to reduce transplant complications and prevent primary graft d…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
This clinical trial update reports a study investigating risk factors that increase the chance of developing primary graft dysfunction after…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation
A University of Pennsylvania-led clinical trial is investigating genetic characteristics that may increase the risk of primary graft dysfunc…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation
The CLAD study investigating biomarkers to predict rejection and outcomes after lung transplantation has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-08-08Clinical Trial Update: Novartis Everolimus Transition [Phase 4]
Clinical trial update for Everolimus transition in phase 4 completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction [Phase 2]
Phase 2 trial of sodium nitrite in lung transplant patients to reduce pulmonary graft dysfunction was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Pneumoproteins Expression in the Organ Donor
This clinical trial entry reports the completion of a study on pneumoprotein expression in organ donors and its relation to primary graft dy…
-
CLINICAL_TRIALS research · 2011-03-02Clinical Trial Update: Quantifying Physical and Biochemical Factors That Contribute to Primary Graft Dysfunction After Lung Transplantation
This clinical trial update investigates physical and biochemical factors contributing to primary graft dysfunction after lung transplantatio…
-
CLINICAL_TRIALS trial_result · 2007-07-25Clinical Trial Update: The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study [Phase 2, Phase 3]
An update on a randomized pilot study evaluating surfactant therapy in lung transplantation to address primary graft dysfunction.